←Back to Expert Scholars
Translational Medicine / 转化医学Liquid Biopsy, Methylation Biomarkers
Emma Kaminski
PhD
🏢Cancer Research UK Cambridge Institute🌐UK
Senior Scientist
30
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Emma Kaminski develops methylation-based cfDNA assays for minimal residual disease and early detection in solid tumors. Her bioinformatic frameworks improve sensitivity at low tumor fractions. She is based at the CRUK Cambridge Institute.
Share:
🧪Research Fields 研究领域
cfDNA methylation
minimal residual disease
early detection
bioinformatics
epigenetics
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Emma Kaminski 的研究动态
Follow Emma Kaminski's research updates
留下邮箱，当我们发布与 Emma Kaminski（Cancer Research UK Cambridge Institute）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment